GEN vs REGN · P/E 17, rev $5.00B vs P/E 14, rev $14.34B
Gen Digital Inc. (GEN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the GEN and REGN stock pages for the full models.
Not investment advice.